Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 14, 2021; 27(2): 224-232
Published online Jan 14, 2021. doi: 10.3748/wjg.v27.i2.224
Table 1 Baseline characteristics of participants
Parameter
Probiotics (n = 64)
Placebo (n = 64)
P value
Age (yr) (mean ± SD)50.25 ± 16.7954.72 ± 14.860.16
Sex (female)24 (37%)22 (34%)0.71
BMI (mean ± SD)25.75 ± 3.4026.29 ± 2.820.33
CRP (mg/L) (mean ± SD)57.32 ± 28.2152.55 ± 24.470.31
Charlson score3.02 ± 1.122.96 ± 0.290.32
Disease etiology
Gallstones-related30 (46%)34 (53%)0.48
Hypertriglyceridemia11 (17%)10 (16%)0.81
Alcohol-related9 (14%)6 (9%)0.41
Others or unknown12 (19%)12 (19%)1.0
Time from first symptoms to admission (d)2 (1–4)3 (1–5)0.10
Follow-up period (d)31.67 ± 1.9731.32 ± 2.130.33